Skip to main content

Table 2 Self-reported prevalence and screening the last 12 months of the main cardiovascular risk factors in Switzerland, overall and by region, 2007

From: Regional differences in self-reported screening, prevalence and management of cardiovascular risk factors in Switzerland

 

Leman

Mittelland

North- West

Zurich

East

Central

Ticino

Switzerland

Test

Sample size

3332

4327

2262

2330

1900

2275

1453

17,879

 

BMI (kg/m2)

24.4 ± 4.2

24.7 ± 4.1

24.6 ± 4.0

24.1 ± 4.0

24.5 ± 4.0

24.4 ± 4.0

24.3 ± 4.2

24.5 ± 4.1

6.68***

BMI (kg/m2)a

24.7 ± 0.1

25.1 ± 0.1

25.0 ± 0.1

24.7 ± 0.1

24.8 ± 0.1

24.8 ± 0.1

24.6 ± 0.1

NA

5.14***

BMI categories (%)

         

   Normal

2050 (61.5)

2489 (57.5)

1326 (58.6)

1519 (65.2)

1137 (59.8)

1412 (62.1)

893 (61.5)

10,826 (60.5)

 

   Overweight

1004 (30.2)

1407 (32.5)

718 (31.8)

636 (27.3)

601 (31.7)

674 (29.6)

425 (29.2)

5465 (30.6)

49.46***

   Obese

278 (8.3)

431 (10.0)

218 (9.6)

175 (7.5)

162 (8.5)

189 (8.3)

135 (9.3)

1588 (8.9)

 

Smoking categories

         

   Current

918 (27.6)

1148 (26.5)

603 (26.7)

680 (29.2)

551 (29.1)

623 (27.4)

389 (26.8)

4912 (27.5)

 

   Former

847 (25.4)

1029 (23.8)

563 (24.9)

520 (22.3)

413 (21.8)

479 (21.1)

320 (22.0)

4171 (23.3)

32.17 *

   Never

1567 (47.0)

2148 (49.7)

1095 (48.4)

1129 (48.5)

933 (49.2)

1173 (51.6)

744 (51.2)

8789 (49.2)

 

Tried to stop smoking

225 (24.5)

282 (24.6)

156 (25.9)

175 (25.7)

160 (29.0)

198 (31.8)

74 (19.0)

1270 (25.9)

25.67***

Hypertension (%)

         

   Screening

2170 (65.1)

2815 (65.1)

1526 (67.5)

1502 (64.5)

1206 (63.5)

1494 (65.7)

972 (66.9)

11,685 (65.4)

10.10NS

   Prevalence

843 (25.3)

1194 (27.6)

678 (30.0)

623 (26.7)

497 (26.2)

552 (24.3)

398 (27.4)

4785 (26.8)

24.96***

   Treatmentb

553 (65.6)

777 (65.1)

430 (63.4)

397 (63.7)

285 (57.3)

357 (64.7)

264 (66.3)

3063 (64.0)

12.26 NS

Dyslipidemia (%)

         

   Screening

1572 (47.2)

1907 (44.1)

969 (42.8)

937 (40.2)

729 (38.4)

862 (37.9)

756 (52.0)

7732 (43.2)

121.8***

   Prevalence

730 (21.9)

825 (19.1)

434 (19.2)

447 (19.2)

308 (16.2)

412 (18.1)

333 (22.9)

3489 (19.5)

39.81***

   Treatmentb

344 (47.1)

380 (46.1)

167 (38.5)

166 (37.1)

105 (34.1)

139 (33.7)

159 (47.8)

1460 (41.8)

43.98***

Diabetes (%)

         

   Screening

1547 (46.4)

1969 (45.5)

1048 (46.3)

1038 (44.6)

818 (43.1)

976 (42.9)

759 (52.2)

8155 (45.6)

39.91***

   Prevalence

193 (5.8)

255 (5.9)

137 (6.1)

132 (5.7)

87 (4.6)

92 (4.0)

77 (5.3)

973 (5.4)

15.84 *

   Treatmentb

125 (64.8)

155 (60.8)

69 (50.4)

65 (49.2)

44 (50.6)

53 (57.6)

45 (58.4)

556 (57.1)

13.49 *

  1. Results are expressed as mean ± SD or as number of patients and (percentage). NA, not assessable. Statistical analysis by analysis of variance or chi-square test: NS; not significant; *, p < 0.05; **, p < 0.01; ***, p < 0.001.a adjusted for gender, education, nationality and marital status; b drug treatment among subjects reporting the risk factor
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us